NK Cell Levels Correlate with Disease Activity in Patients with Multiple Sclerosis on Ocrelizumab/Rituximab Therapy

• Автори: Simone Dal Bello (Автор), Simone Lorenzut (Автор), Emma Saccomano (Автор), Yan Tereshko (Автор), Gian Luigi Gigli (Автор), Carlo Ennio Pucillo (Автор), Mariarosaria Valente (Автор)
• Формат: Книга
• Опубліковано: MDPI AG, 2024-01-01T00:00:00Z.
• Предмети: article
• Онлайн доступ: Connect to this object online.

Background: Recently, research on the pathogenesis of multiple sclerosis (MS) has focused on the role of B lymphocytes and the possibility of using specific drugs, such as Ocrelizumab and Rituximab, directed toward these cells to reduce inflammation and to slow disease progression. Objective: We aim...